Welcome to our dedicated page for EUDA HEALTH HOLDINGS news (Ticker: LAXXU), a resource for investors and traders seeking the latest updates and insights on EUDA HEALTH HOLDINGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect EUDA HEALTH HOLDINGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of EUDA HEALTH HOLDINGS's position in the market.
8i Acquisition 2 Corp. (NASDAQ: LAXXU) closed its initial public offering on November 22, 2021, raising $86,250,000 by selling 8,625,000 units at $10.00 each. The offering included an over-allotment of 1,125,000 units. Each unit comprises one ordinary share, one warrant for half a share, and one right for one-tenth of a share upon a business combination. The company is a special purpose acquisition company (SPAC) aiming to merge or acquire potential businesses. Maxim Group LLC served as the sole book-running manager for this offering.
8i Acquisition 2 Corp announced the pricing of its initial public offering (IPO) on November 22, 2021. The offering will consist of 7,500,000 units priced at $10.00 each, including one ordinary share, one redeemable warrant, and one right for a fractional share. Trading on Nasdaq under the ticker symbol LAXXU is set to commence on the same day, with the closing of the offering anticipated on November 24, 2021. Maxim Group LLC is the sole book-running manager, and a 45-day overallotment option for 1,125,000 additional units is available.
